|
10 Companies |
|
7 Products |
|
7 Products |
|
13 Mechanisms of Action |
|
0 Trials |
|
31 News |
|
- | Trial completion, Enrollment change: Immune Reactions in Contact Dermatitis Affected Skin (clinicaltrials.gov) - Jun 20, 2018
P=N/A, N=9, Completed, Sponsor: Rockefeller University
Enrolling by invitation --> Completed | N=120 --> 9
- | Enrollment change: Immune Reactions in Contact Dermatitis Affected Skin (clinicaltrials.gov) - Jun 8, 2017
P=N/A, N=120, Enrolling by invitation, Sponsor: Rockefeller University
Enrolling by invitation --> Completed | N=120 --> 9 N=500 --> 120
- | Trial completion, Enrollment change, Trial primary completion date: Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy (clinicaltrials.gov) - Apr 12, 2017
P=N/A, N=400, Completed, Sponsor: Region Skane
N=500 --> 120 Recruiting --> Completed | N=600 --> 400 | Trial primary completion date: Jan 2017 --> Sep 2016
- ||| Trial completion: Human Photoallergy Test (824/2016) (clinicaltrials.gov) - Jan 10, 2017
P=N/A, N=53, Completed, Sponsor: Bayer
Recruiting --> Completed | N=600 --> 400 | Trial primary completion date: Jan 2017 --> Sep 2016 Recruiting --> Completed
- ||| New trial: Human Photoallergy Test (824/2016) (clinicaltrials.gov) - Nov 13, 2016
P=N/A, N=55, Recruiting, Sponsor: Bayer
- Trial completion, Enrollment change, Trial primary completion date: Epidemiology and Co-Reactivity of Novel Surfactant Allergens (clinicaltrials.gov) - Sep 26, 2016
P=N/A, N=48, Completed, Sponsor: Minneapolis Veterans Affairs Medical Center
Recruiting --> Completed Enrolling by invitation --> Completed | N=100 --> 48 | Trial primary completion date: Sep 2017 --> Sep 2016
- Enrollment open, Trial primary completion date: Epidemiology and Co-Reactivity of Novel Surfactant Allergens (clinicaltrials.gov) - Sep 22, 2016
P=N/A, N=100, Enrolling by invitation, Sponsor: Minneapolis Veterans Affairs Medical Center
Enrolling by invitation --> Completed | N=100 --> 48 | Trial primary completion date: Sep 2017 --> Sep 2016 Not yet recruiting --> Enrolling by invitation | Trial primary completion date: Aug 2016 --> Sep 2017
- ||| Trial completion: 18850 - Human Photoallergy Test (clinicaltrials.gov) - Aug 4, 2016
P=N/A, N=54, Completed, Sponsor: Bayer
Not yet recruiting --> Enrolling by invitation | Trial primary completion date: Aug 2016 --> Sep 2017 Active, not recruiting --> Completed
- ||| Trial completion: Human Photoallergy Test (clinicaltrials.gov) - Aug 2, 2016
P=N/A, N=54, Completed, Sponsor: Bayer
Active, not recruiting --> Completed Recruiting --> Completed
- ||| Trial completion: Human Photoallergy Test (clinicaltrials.gov) - Jul 27, 2016
P=N/A, N=54, Completed, Sponsor: Bayer
Recruiting --> Completed Recruiting --> Completed
- ||| Trial completion: 18793 - Human Photoallergy Test (clinicaltrials.gov) - Jul 27, 2016
P=N/A, N=54, Completed, Sponsor: Bayer
Recruiting --> Completed Active, not recruiting --> Completed
- ||| New trial: 18349-Human Photoallergy Test (clinicaltrials.gov) - Jul 6, 2016
P=N/A, N=60, Completed, Sponsor: Bayer
- ||| Enrollment open: Human Photoallergy Test (clinicaltrials.gov) - Jul 6, 2016
P=N/A, N=55, Recruiting, Sponsor: Bayer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- || Enrollment closed: 18793 - Human Photoallergy Test (clinicaltrials.gov) - Jun 24, 2016
P=N/A, N=55, Active, not recruiting, Sponsor: Bayer
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||| Enrollment open: Human Photoallergy Test (clinicaltrials.gov) - Jun 20, 2016
P=N/A, N=55, Recruiting, Sponsor: Bayer
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Enrollment closed: 18850 - Human Photoallergy Test (clinicaltrials.gov) - May 31, 2016
P=N/A, N=50, Active, not recruiting, Sponsor: Bayer
Not yet recruiting --> Recruiting Not yet recruiting --> Active, not recruiting
- Enrollment change, Trial withdrawal: 18776 - Human Photoallergy Test (clinicaltrials.gov) - May 25, 2016
P=N/A, N=0, Withdrawn, Sponsor: Bayer
Not yet recruiting --> Active, not recruiting N=55 --> 0 | Not yet recruiting --> Withdrawn
- ||| Enrollment open: 18793 - Human Photoallergy Test (clinicaltrials.gov) - May 25, 2016
P=N/A, N=55, Recruiting, Sponsor: Bayer
N=55 --> 0 | Not yet recruiting --> Withdrawn Not yet recruiting --> Recruiting
- Enrollment status: Immune Reactions in Contact Dermatitis Affected Skin (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=500, Enrolling by invitation, Sponsor: Rockefeller University
Not yet recruiting --> Recruiting Recruiting --> Enrolling by invitation
- ||| New trial: 18850 - Human Photoallergy Test (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=60, Not yet recruiting, Sponsor: Bayer
- ||| New trial: Human Photoallergy Test (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=55, Not yet recruiting, Sponsor: Bayer
- ||| New trial: 18776 - Human Photoallergy Test (clinicaltrials.gov) - Apr 26, 2016
P=N/A, N=55, Not yet recruiting, Sponsor: Bayer
- ||| New trial: Human Photoallergy Test (clinicaltrials.gov) - Apr 25, 2016
P=N/A, N=55, Not yet recruiting, Sponsor: Bayer
- ||| New trial: 18793 - Human Photoallergy Test (clinicaltrials.gov) - Apr 25, 2016
P=N/A, N=55, Not yet recruiting, Sponsor: Bayer
- New trial: Epidemiology and Co-Reactivity of Novel Surfactant Allergens (clinicaltrials.gov) - Aug 27, 2015
P=N/A, N=100, Not yet recruiting, Sponsor: Minneapolis Veterans Affairs Medical Center
- | MRX 6 / Akari Therap
Trial completion, Enrollment change, Trial primary completion date: Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis (clinicaltrials.gov) - Apr 21, 2015
P1/2, N=13, Completed, Sponsor: Hadassah Medical Organization
Recruiting --> Enrolling by invitation Recruiting --> Completed | N=80 --> 13 | Trial primary completion date: Dec 2012 --> Apr 2013
- Prolia (denosumab) / Amgen, Daiichi Sankyo, Samcyprone (diphenylcyclopropenone) / Phio Pharma
Trial completion, Trial primary completion date, IO biomarker: Effect of RANKL Inhibition on UV-induced Immunosuppression (clinicaltrials.gov) - Jul 24, 2014
P1, N=31, Completed, Sponsor: Innovaderm Research Inc.
Recruiting --> Completed | N=80 --> 13 | Trial primary completion date: Dec 2012 --> Apr 2013 Recruiting --> Completed | Trial primary completion date: Oct 2014 --> Jun 2014
- Enrollment open: Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy (clinicaltrials.gov) - Nov 18, 2013
P=N/A, N=600, Recruiting, Sponsor: Region Skane
Recruiting --> Completed | Trial primary completion date: Oct 2014 --> Jun 2014 Not yet recruiting --> Recruiting
- Prolia (denosumab) / Amgen, Daiichi Sankyo, Samcyprone (diphenylcyclopropenone) / Phio Pharma
Enrollment open, IO biomarker: Effect of RANKL Inhibition on UV-induced Immunosuppression (clinicaltrials.gov) - Nov 6, 2013
P1, N=30, Recruiting, Sponsor: Innovaderm Research Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Prolia (denosumab) / Amgen, Daiichi Sankyo, Samcyprone (diphenylcyclopropenone) / Phio Pharma
New P1 trial, IO biomarker: Effect of RANKL Inhibition on UV-induced Immunosuppression (clinicaltrials.gov) - Nov 5, 2013
P1, N=30, Recruiting, Sponsor: Innovaderm Research Inc.
- ||| MRX 6 / Akari Therap
Trial initiation date: Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis (clinicaltrials.gov) - Mar 24, 2012
P1/2, N=80, Recruiting, Sponsor: Hadassah Medical Organization
Not yet recruiting --> Recruiting Initiation date: May 2009 --> Mar 2011